Skip to main content

Table 4 Five key PRES domains [17, 18] with additions (bold) from synthesis of included studies results

From: Paediatric eye and vision research participation experiences: a systematic review

Domains

Dimensions of domains

Examples provided

Authors’ recommendations

Relationship with research staff

Extent to which content and character of interactions with research staff meet or exceed participant expectations

Friendliness

Professionalism

Knowledge

Approachability

Helpfulness

Respectfulness

Responsiveness

“Informativeness”

“Appreciativeness”

Staff have appropriate training (support) and sufficient time to build relationships

Quality and timeliness of information

Range of formats and media

Accessibility and breath of formats to suit needs and expectations, e.g. written, verbal, video, online, SMS

Ensure the right information is available in the right place at the right time as participants proceed through the study

Content, accuracy and comprehensiveness

Pre-consent information (Participant information sheet (PIS))

General information about the health condition

‘Practical’ process information, e.g. appointments, what to expect, where to be, when and how

Updates and progress of the study

Personal information, e.g. test results

Overall study results

Responsiveness

Responsive to questions

Engagement with diverse participant motivations

Extent to which study design/delivery satisfies a range of differing motivations for participation:

▪Altruistic

▪Health related

Opportunity for (relatively) flexible treatment options

Opportunity to relinquish personal responsibility for unforeseen effects whilst trying new treatment

Material incentives designed in by researchers

Altruistic

Wanting to help others

Health related

Improved monitoring and care of own condition

Hope of improvement in personal medical condition

Improved understanding of personal condition

Opportunity for (relatively) flexible treatment options

Join randomised controlled trial (RCT) with a chance of receiving trial intervention, always with the freedom to withdraw (and potentially seek treatment off study)

Join RCT and be randomised to non-intervention, but still have the opportunity for intervention later

Opportunity to relinquish personal responsibility for unforeseen effects whilst trying new treatment

RCT – willingly surrender to random allocation of treatment

Material incentives designed in by researchers

Thank you materials

Condition specific equipment/servicing of equipment

Actively appreciate participants motivations

Study organisation

Extent to which study and intervention design/delivery accommodates participants’ time, monetary and physical/emotional costs

Appointment scheduling—frequency, length of time, flexibility

Waiting times in clinic/between clinics

Assessment burden/discomfort/distress

Monetary expenses and how/when incurred/reimbursed

Access including location proximity/convenience (any flexibility), travel and parking costs/time/burden

Access for those with disabilities (visual impairment, wheelchair access, etc.)

Unpleasant side effects or implications of intervention

Lifestyle adaptions to accommodate intervention

Involve patients and the public in the earliest stages of the study and intervention design, to identify and mitigate factors which may contribute to adverse participant experiences

‘Walk-throughs’ to carefully consider participants’ pathway from pre-consent, through all study visits

Study environment

Extent to which research environments meet participants’ preferences and expectations

Noise levels

Ambience (calm/busy)

Attitudes of others (non-research related) in the environment

Availability of refreshments

Carefully consider the effects of the environment participants will be moving through